Viewing Study NCT04217993


Ignite Creation Date: 2025-12-25 @ 1:05 AM
Ignite Modification Date: 2026-01-01 @ 6:37 PM
Study NCT ID: NCT04217993
Status: COMPLETED
Last Update Posted: 2023-04-20
First Post: 2019-11-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Jaktinib for the Treatment of Ruxolitinib Intolerance of Myelofibrosis
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module